Gastric Cancer

Amarillo Biosciences Receives Grant To Develop H. pylori Vaccine

Published in Vaccine Weekly, November 7th, 2001

Amarillo Biosciences, Inc. has received a Small Business Innovative Research (SBIR) grant from the U.S. National Institutes of Health (NIH) for $96,248 to be used to develop a vaccine to combat Helicobacter pylori, a major cause of gastric cancer.

Amarillo Biosciences will collaborate with Steven Krakowka, DVM, PhD, of the Ohio State University and John Ellis, DVM, PhD, of Capricorn Research and Development, Laramie, Wyoming.

H. pylori is a spiral-shaped bacterium that is found in the stomach of humans in which it causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers. Approximately two-thirds of the world's human...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-11-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry